Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and E for RLS in ESRD
NCT05350124Phase 3Unknown
- Sponsor
- King Abdulaziz University
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of ascorbic acid, tocopherol in restless legs syndrome (RLS), sponsored by King Abdulaziz University. Status: unknown.
02
Drugs
ascorbic acidtocopherol
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT05350124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05350124.